Chronic obstructive pulmonary disease (COPD) is characterized by unresolved neutrophilic airway inflammation, and is caused by chronic exposure to toxic gases, such as cigarette smoke (CS), in genetically susceptible individuals. Recent data indicate a role for Damage Associated Molecular Patterns (DAMPs) in COPD. Here, we investigated the genetics of CS-induced DAMP release in 28 inbred mouse strains monitored previously for CSinduced neutrophilic airway inflammation. Subsequently, in lung tissue from a subset of strains the expression of the identified candidate genes was analyzed. We tested whether siRNA-dependent knockdown of candidate genes altered the susceptibility of the human A549 cell line to CS-induced cell death and DAMP release.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a severe and progressive inflammatory lung disease, characterized by both chronic bronchitis and emphysema. COPD is mainly caused by chronic exposure to noxious gases and particles, including cigarette smoke (CS) 6 . Nevertheless, approximately 30% of COPD patients is a never smoker, indicating that also other factors, including biomass smoke exposure, air pollution, pre-natal factors and genetics contribute to the inception of COPD. 37 Moreover, only 20% of the smoking population develops COPD, 45 further indicating that genetic susceptibility is important for the onset of COPD. To date, treatment options for COPD are limited, and current treatments are aimed at reducing the severity of symptoms and reducing the number and severity of exacerbations, without addressing the underlying cause of the disease. Therefore, a more detailed understanding of disease pathophysiology is imperative for the identification of novel treatment options.
During the early stages of COPD, airway inflammation is characterized by extensive activation of the innate immune system, while at later stages of the disease the adaptive immune system is also involved 12 . A mechanism triggering activation of innate immune responses is the release of damage associated molecular patterns (DAMPs). DAMPs are a heterogeneous group of molecules that possess a wide variety of functions under physiological conditions 5 . Upon cellular damage and necrosis, DAMPs are released from the cells and act as endogenous danger molecules that alarm and activate the innate immune system 31 . Although DAMPs are a heterogeneous group of molecules, they all have in common that upon release from damaged or necrotic cells, they can activate one or several pattern recognition receptors (PRRs), including toll-like receptors (TLRs) and the receptor for advanced glycation end-products (RAGE) 47 . The activation of PRRs leads to activation of inflammatory pathways, including nuclear factor-κB (NFκB), inducing the release of inflammatory cytokines, including IL-6, IL-8 and TNF-α 44 . The release of these cytokines, together with the direct effect of some DAMPs, leads to the attraction of several innate immune cells including neutrophils and inflammatory monocytes to the site of tissue damage 47 . Recently, we postulated that DAMPs may play a crucial role in the pathophysiology of COPD, as inhaled CS induces damage to lung resident cells such as the airway epithelium, leading to the release of DAMPs and subsequent production of pro-inflammatory cytokines, which causes neutrophilic airway inflammation 47 . Indeed, several DAMPs are increased in COPD patients compared to both smoking and nonsmoking controls, including Heat shock protein (HSP)60/70 in serum 47 , S100A8/A9 in bronchoalveolar lavage (BAL) fluid 40 , the human cathelicidin peptide LL-37 in sputum and BAL fluid 59, 27 and High mobility group box 1 (HMGB1) in BAL fluid, sputum, serum and epithelial lining fluid (ELF) 14, 25, 28 . Furthermore, the gene encoding RAGE, AGER, has been identified as a susceptibility gene for lung function decline and COPD development 7, 8, 51 . Together, these data indicate that DAMPs may play a pivotal role in the pathophysiology of COPD.
Genetic susceptibility for COPD is complex and is regulated by many different genes 42 . To increase the knowledge about the genetics of COPD, it is important to study the pathways that lead to emphysema and neutrophilic airway inflammation separately. Some studies have been performed investigating the genetics of emphysema 8 . In contrast, limited data are available investigating the genetics underlying the susceptibility to neutrophilic airway inflammation. Previously, it was found that neutrophilic airway inflammation already occurs upon short-term smoke exposure in susceptible mice and humans 43, 56 . We recently performed a genetic screen using 28 inbred mouse strains and identified several susceptibility genes for short-term CS-induced neutrophilic airway inflammation in mice using haplotype association mapping (HAM) 46 . This approach has previously been shown effective for identifying susceptibility genes for acrolein-, chlorine-, or ventilator-induced acute lung injury [33] [34] [35] [36] . In a separate study using a subset of mice from this screen, we found that mice susceptible for CSinduced neutrophilic airway inflammation display a different DAMP-release-profile in BAL fluid compared to mice that are not susceptible for CS-induced neutrophilic airway inflammation 48 . Therefore, we hypothesize that an increased susceptibility for CS-induced DAMP release leads to increased CS-induced neutrophilic airway inflammation. Here, we further explored the effect of genetic susceptibility for neutrophilic airway inflammation on DAMP release and studied which genes regulate CS-induced DAMP release, using in vitro, in vivo and in silico approaches.
In these studies, we have identified two novel candidate genes for the susceptibility to CS-induced DAMP release and show that these genes contribute to the susceptibility for CS-induced airway inflammation, indicating that the tendency for CS-induced DAMP release may contribute to the susceptibility for COPD.
MATERIALS & METHODS

Experimental Design
This study was performed after approval from the Institutional Animal Care and Use Committee of the University of Groningen (IACUC-RuG). For this study 28 inbred mouse strains (females, age 8-10 weeks; n = 16 mice/strain, The Jackson Laboratory, Bar Harbor, ME, USA) were exposed to gaseous-phase CS from Kentucky 3R4F research reference cigarettes (Tobacco Research Institute, University of Kentucky, Lexington, USA) or air as control as described before 50 . In short, filters were removed from each cigarette before being smoked in five minutes at a rate of 5 L/hr and mixed with ambient air at a rate of 60 L/hr using whole body exposure in 6-liter Perspex boxes. Female mice (n=8 per group) were exposed to CS of 1-5 cigarettes or filtered air (n=8 per group) for five consecutive days, with two exposures per day 50 . Mice were euthanized two hours after the final exposure session ( Figure 1A ). Lung tissue (four individual lobes) and BAL fluid (1 ml, 100 μl aliquots) were collected and stored at -80 C° until further use. BAL neutrophil counts were analyzed using differential cell counts performed with cytospin smears using the May-Grünwald Giemsa method 2 .
Haplotype Association Mapping analysis
Haplotype association mapping was performed for the log-transformed BAL dsDNA levels as described before, using the efficient mixed-models association (EMMA) which conducts tests for association on single SNPs with two alleles and is corrected for confounding from population structure and genetic relatedness 29, 4, 50 . The analysis was performed using a high-density SNP map of 4x10 6 SNPs. The publicly available R-package implementation of EMMA (available at http://mouse.cs.ucla.edu/emma/) was used. The standard significance threshold of -log (P) = 5 was used 4, 30 .
DAMP measurements and gene expression analysis
DAMPs were measured in cell free BAL fluid using ELISA for HSP70 (Human/Mouse/Rat Total HSP70/HSPA1A DuoSet R&D systems, Minneapolis, USA) and HMGB1 (HMGB1 Detection Kit, Chondrex inc., Redmond WA, USA), using the Quant-iT™ PicoGreen® dsDNA Assay Kit for dsDNA (Invitrogen, Carlsbad CA, USA) and quantitative real-time (qRT-)PCR using iTaq Universal SYBR® Green Supermix (Bio-Rad, Richmond, CA, USA) for mtDNA as described before 60 . Primers for mouse cytochrome c oxidase III (Mtco3), 5'-ACGAAACCACATAAATCAAGCC-3' (Forward) and 5'-TAGCCATGAAGAATGTAGAACC-3' (Reverse) were synthesized and purchased from Invitrogen (Carlsbad, USA). Standard curves for mtRNA were prepared using purified mtDNA as targets.
For mRNA expression analyses RNA was isolated from lung tissue homogenate using Trizol (Invitrogen, Carlsbad, USA). Further purification of RNA was performed using RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA), and any remaining DNA was removed using the RNase-Free DNase Set (Qiagen, Valencia, CA, USA).
The total amount of RNA was quantified using a Nanodrop-1000 (Nanodrop Technologies, Wilmington, USA).
Afterwards, cDNA synthesis was performed according to the manufacturer's protocol using the iScript cDNA synthesis kit (Bio-Rad, Richmond, CA, USA). Quantification of cDNA targets was performed with the TaqMan technology using the ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). All reactions were run in duplicate. Normalization was performed using multiple housekeeping genes (HKG), which were included on each plate (B2m, Ipo8, Pgk1). The level and stability of expression of the HKGs were determined in all samples and the most appropriate set of HKGs was chosen (Ipo8 and Pgk1 in all cases in this manuscript) using NormFinder. 1 Gene expression analyses were performed using commercially available primer/probe sets specific for target genes (Invitrogen Life Technologies, Carlsbad CA, USA), Aox3l1 (Mm01255397_m1), Arhgap44
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| Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice VII (Mm00477078_m1) and Trip11 (Mm01336257_m1). Genotypes were determined using the publicly available Jackson Laboratory mouse SNP database (available at http://cgd.jax.org/cgdsnpdb/).
Cell culture and CSE stimulation
The human bronchial epithelial cell-lines, 16HBE (kindly provided by Dr. DC Gruenert; University of California, San Francisco, California, USA) and Beas2B (ATCC, CRL-9609) and the adenocarcinoma human alveolar cell-line A549 were cultured in RPMI-1640 supplemented with 10% fetal calf serum (FCS; Biowhittaker, Verviers, Belgium), 100 U/ml penicillin and 100 mg/ml streptomycin. Before usage, cells were grown to confluence and serumdeprived overnight. Cigarette smoke extract (CSE) was prepared using two Kentucky 3R4F research-reference filtered cigarettes and a Watson Marlow 603S smoking pump at a rate of 8 L/hr (Watson-Marlow, Delden, The Netherlands). Before use, filters were cut from both of the cigarettes. The gaseous-phase CS of two cigarettes was led through 25 ml of RPMI-1640 medium supplemented with 100 U/ml penicillin and 100 mg/ml streptomycin, and this solution was set at 100% CSE.
siRNA transfection
Down-regulation of candidate genes was performed with commercially available siRNA assays according to manufacturer's protocol (MISSION® esiRNA for PPT1 and ELAC2, Sigma-Aldrich, Saint-Louis MO, USA), using RNAiMAX lipofectamine as a transfection reagent (Invitrogen, Carlsbad CA, USA). Cells were exposed to various concentrations of CSE for four hours before being incubated with serum-and CSE-free medium for 16 hours.
The levels of dsDNA and RNA were determined in cell free supernatant using the Quant-iT™ Pico-and Ribo-Green® dsDNA Assay Kits respectively (Invitrogen). The percentage of viable, apoptotic and necrotic cells were determined using an Annexin-V (Immunotools, Friesoythe, Germany) and Propidum Iodide (PI; Sigma-Aldrich, Saint Louis, USA) staining for flow cytometry.
Human gene expression analysis
The study was approved by the Medical Ethics Committee of the University Medical Center Groningen and all subjects gave their written informed consent. The study protocol was consistent with the Research Code of the UMCG (http://www.rug.nl/umcg/onderzoek/researchcode) and national ethical and professional guidelines (htttp://www.federa.org).Young healthy individuals were classified as susceptible when the prevalence of COPD in smoking first or second degree relatives older than 40 years meets the following criteria: 2 out of 2, 2 out of 3, 3 out of 3, 3 out of 4 or 4 out of 4 smoking family members have developed COPD and were classified as non-susceptible when none of the smoking first or second degree relatives who are at least 40 years of age (at least two should be identified) have been diagnosed with COPD. Subjects were included in the study if they had smoked only occasionally and were able to start or stop smoking on demand. Bronchial brushings for gene expression profiling were performed after smoking three cigarettes within three hours and after a smoking cessation period of at least 48 hours (n=3). The change in bronchial epithelial gene expression before and after smoking of three cigarettes was determined using a linear regression analysis with time defined as a categorical variable with two levels (1 = baseline, 2 = after smoking of three cigarettes), adjusted for age and gender as possible confounding variables. Ge ij represents the log2 gene expression value for a gene in sample i from patient j, ε ij represents the error that is assumed to be normally distributed:
The change in bronchial epithelial gene expression before and after smoking of three cigarettes was determined between young occasional smokers either susceptible or non-susceptible for COPD. This analysis was performed using a linear mixed effects model with time defined as a categorical variable with two levels (1 = baseline, 2 = after smoking of three cigarettes) adjusted for age and gender. Ge ij represents the log2 gene expression value for a gene in sample i from patient j, ε ij represents the error that is assumed to be normally distributed and α j represents the patient random effect:
Ge ij = β 0 + β 1 X Age-i + β 2 X Gender-i + β 3 X susceptibility for COPD-i + β 4 X Time-i + β 3 X susceptibility for COPD-i :β 4 X Time-i
Statistical analysis
All data is shown as mean ± SEM except for mRNA expression data which is shown as box-whisker plots indicating the mean ± interquartile range, with the whiskers indicating the highest and lowest data point. A Mann-Whitney U test was used to test for differences between groups. To test for differences in basal gene expression between mouse strains a one-way ANOVA with Turkey's multiple comparison correction was performed. Normality in distribution of BAL dsDNA levels was tested using the Shapiro-Wilk normality test, with a significance threshold of p = <0.05. Correlations were determined using a linear regression analysis, with a significance threshold of p value of p = <0.001.
RESULTS
Susceptibility for cigarette smoke-induced DAMP release is genetically determined
In order to investigate whether susceptibility to CS-induced neutrophilia can be explained by differences in DAMP release, we made use of a previously established dataset from a genetic screen where 28 different inbred mouse strains were exposed to CS for five consecutive days ( Figure 1A ) 46 . We measured the levels of four wellknown DAMPs, HSP70, HMGB1, mtDNA and dsDNA, in BAL fluid upon air-and CS exposure ( Figure 1B -E). While basal (air-exposed) levels of all DAMPs showed some variation between strains (Figure 2) , the CS-induced DAMP levels varied more extensively between strains for all four DAMPs studied. This was most pronounced for dsDNA, in which CS exposure induced a 6-fold induction in BAL fluid of BALB/cByJ, the most susceptible strain for neutrophilic airway inflammation, and a 0.1 fold decrease in the non-susceptible I/LnJ strain, while its levels did not strongly differ between the strains at baseline ( Figure 3 ).
Next, we investigated whether the number of neutrophils in BAL fluid of 28 mouse strains after CS exposure correlated with the levels of DAMPs in the BAL fluid after CS exposure. A strong and significant correlation between dsDNA and airway neutrophilia (r=0.8077, p≤0.0001) was found ( Figure 4A ), but not for HMGB1 (r=0.061, p=0.349), HSP70 (r=0.0227, p=0.7276) or mtDNA (r=0.0177, p=0.7886) ( Figure 4B-D) .
These data show that CS-induced DAMP release varies largely between different mouse strains, indicating the contribution of a genetic component to the magnitude of this response. Furthermore, of the four DAMPs analyzed, dsDNA showed the largest variation between strains and showed the strongest correlation with CSinduced airway neutrophilia, making dsDNA most relevant for further investigation.
Identification of susceptibility genes for basal and CS-induced BAL dsDNA levels in mice
In order to investigate which genes are associated with the basal dsDNA release in mice, a haplotype association mapping (HAM) analysis was performed using the efficient mixed-models association (EMMA) 33, 46 software on the log-transformed dsDNA levels in 28 different inbred mouse strains. BAL dsDNA levels in air-exposed mice strongly correlated with CS-induced dsDNA levels after removal of the outliers BALB/c and BALB/cByJ (r=0.7019, p≤0.0001), indicating that dsDNA release is, at least in part, regulated by mechanisms that operate irrespective of CS exposure ( Figure 3C ). Therefore, we first analyzed BAL dsDNA levels in both mice groups, using CS exposure as a covariate for the analysis. This analysis identified 99 SNPs associated with dsDNA levels with genome-wide significance ( Table 1) , of which 49 were located within a gene and had less than six mouse strains with missing data ( Table 2 ). The genes significantly associated with dsDNA release consist of Aox3l1 (2 SNPs) and Cflar (1 SNP) on chromosome 1, Arhgef11 (3 SNPs) on chromosome 3, Ppt1 (1 SNP) and Cap1 (4 SNPs) on chromosome 4, Elac2
(2 SNPs), Arhgap44 (26 SNPs) and Myocd (7 SNPs) on chromosome 11 and Trip11 on chromosome 12 (3 SNPs) ( Figure 5 ).
Next, we analyzed which SNPs were specifically associated with the CS-induced dsDNA levels, using the log-transformed BAL dsDNA levels of smoke-exposed mice only as input for the analysis. Using all 28 mouse strains available in the EMMA database no significant hits were found. This may be caused by the extreme effect of CS exposure on BAL dsDNA levels in the BALB/cJ and the BALB/cByJ strains, acting as outliers in the analysis. Therefore, these strains were removed from the HAM analysis for CS-induced dsDNA release. This second analysis identified 48 significant SNPs specifically associated with CS-induced dsDNA levels (Table 3) , of which 18 were 101 | Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice
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Figure 1: Cigarette smoke-induced damage associated molecular pattern (DAMP) release in bronchoalveolar lavage (BAL) fluid from 28 inbred mouse strains. (A)
Schematic representation of the experimental setup. Mice were exposed to cigarette smoke or control air for 5 consecutive days. For each cigarette smoke exposure session, 1, 3, or 5 cigarettes (Cig) were used with 2 exposures per day, except on the fifth day when only 1 exposure session was performed. Mice were euthanized 2 hour after the final exposure on the fifth day. Bronchoalveolar lavage fluid (BAL) fluid, lung tissue, serum, and skeletal muscle samples were isolated, aliquoted, and stored at -80°C until further use. The cigarette smoke-induced levels of (B) Heat shock protein 70 (HSP70), (C) High mobility group box 1 (HMGB1), (D) mitochondrial (mt)DNA and (E) double-stranded (ds)DNA in BAL fluid of 28 inbred mouse strains are shown. Bars depict average and standard error of the mean (SEM) of the ratio of smoke-exposed mice (n=8) to the average of air-exposed mice (n=8). Significance between DAMP levels of mice exposed to CS and mice exposed to air was tested using a Mann Whitney-U test, * = P<0.05. located within a gene and had less than six mouse strains with missing data (Table 4 ). The genes significantly associated with CS-induced dsDNA release are Ppt1 (1 SNP) and Cap1 (1 SNP) on chromosome 4, Dscaml1 (1 SNP) on chromosome 9, Myocd (6 SNPs) on chromosome 11 and Enox1 on chromosome 14 (9 SNPs) ( Figure 6 ).
Three of the genes associated with CS-induced dsDNA levels, Ppt1, Cap1 and Myocd, were also associated with the basal dsDNA levels in the analysis corrected for CS exposure status, indicating that only two genes, Dscaml1 and Enox1, are specifically associated with CS-induced dsDNA release. Upon inspection of the gene ontology of the 11 genes associated with overall or CS-induced dsDNA release, we did not identify a single pathway in which all genes operate (Table 5 ). However, several of these genes, i.e. Cflar, Ppt1, Cap1, Enox1 and Elac2, are involved in apoptosis and DNA damage responses. Significance cut-of is set at -log(P)≥6. Major and minor alleles indicate the number of mouse strains with the most and least abundant allele for the SNP. Missing alleles indicate the number of mouse strains with missing data for the SNP.
Gene expression of candidate genes in lung tissue of mice susceptible or non-susceptible for CS-induced dsDNA release
In order to identify differences in gene expression between mouse strains susceptible and non-susceptible for CS-induced dsDNA release, two susceptible mouse strains, BALB/cByJ and PL/J, and two non-susceptible mouse strains, C58/J and A/J, were selected for further analysis. The basal mRNA expression of the 11 candidate genes identified using HAM analysis was determined in these strains (Figure 7) . The two susceptible mouse strains showed a higher basal expression of Ppt1 compared to the non-susceptible mouse strains, while the expression of Enox1 was only higher in the susceptible BALB/cByJ strain. In contrast, the expression of Elac2 was higher in the two non-susceptible mouse strains. For Arhgap44, Arhgef11, Cap1 and Trip11 the expression is the lowest in the non-susceptible A/J strain but with also low expression in the susceptible BALB/cByJ strain, while for Dscaml1, Aox3l1 and Myocd the highest basal expression was found in the C58/J strain. Finally for Cflar no differences in basal gene expression were shown between the different strains. The overall differences in basal mRNA expression levels between strains were relatively small and only for Ppt1 and Elac2 an association with genotype was found.
Next, we identified the effect of CS exposure on gene expression of the 11 candidate genes by measuring the mRNA expression in lung tissue of the two susceptible and two non-susceptible mouse strains exposed to air Significant SNPs located within a gene and had less than six mouse strains with missing data. Significance cut-of is set atlog(P)≥6. Number of major and minor alleles indicate the number of mouse strains with the most and least abundant allele for the SNP from the 28 mouse strains used in our analyses. Number of missing alleles indicate the number of mouse strains with missing data for the SNP. Function class is intronic (Int), synonymous-codon (Cs) with the amino acid and location or 3'-untranslated region (UTR). Missing information is noted as unknown (uk). Position is the base pair location of the SNP.
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or smoke (Figure 8 ). Here, CS exposure leads to a decrease in Arhgef11, Elac2, Enox1 and Trip11 gene expression in at least one of the non-susceptible mouse strains. This effect was even stronger for Dscaml1, where the mRNA expression was not only decreased by CS exposure in the non-susceptible strains but also significantly increased by CS in the susceptible mouse strains. In contrast, CS leads to a decrease in Ppt1 gene expression for both susceptible mouse strains and in Myocd gene expression for the susceptible BALB/cByJ strain. For Aox3l1, Arhgap44 and Cflar hardly any effect of CS exposure on gene expression was shown. Only for Ppt1 and Elac2 the effects of CS exposure on gene expression levels in lung tissue were in accordance with the identified genotypes.
Together, we found small, yet significant differences in the basal mRNA expression levels between different strains. However, only for Ppt1 and Elac2 this was accordance with the genotype, indicating that these SNPs might function as an expression quantitative trait locus (eQTL). CS exposure induced changes in gene expression of the candidate genes in specific strains, with the strongest effect on Dscaml1, which increased in the susceptible strains and decreased in at least one non-susceptible strain. Furthermore, for Ppt1 the decrease in expression was only noted in susceptible mouse strains, while for Elac2 the CS-induced decrease in gene expression was only noted in non-susceptible mouse strains. These data indicate that for these two genes the effect of CS on their gene expression regulation may contribute to differences in susceptibility for CS-induced dsDNA release in the mouse model.
Down regulation of candidate genes in human alveolar epithelial cells influences CS-induced cell death and DAMP release
Since Ppt1 and Elac2 showed an interaction between the effect of their expression regulation and susceptibility for CS-induced dsDNA release, we selected these two genes for further investigation. We studied the effect of down-regulation of the candidate genes in human lung epithelial cells on CS-extract (CSE)-induced cell death and DAMP release. First, we tested which of three human lung epithelial cell lines was most suitable for CSE-induced dsDNA release experiments. Therefore, the bronchial epithelial cell lines 16HBE and BEAS-2B and the adenocarcinoma alveolar cell line A549 were exposed to 0-100% of CSE for four hours. After extensive washing and incubation for another 16 hours on CSE-free medium, the amount of dsDNA in the cell free supernatant was determined.
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Neither BEAS-2B nor 16HBE cells showed a significant increase in the amount of dsDNA release upon CSE exposure, while A549 cells showed a dose-dependent increase in the amount of dsDNA that is released upon CSE exposure ( Figure 9A) . Therefore, further experiments to test the effects of the selected candidate genes on CS-induced dsDNA release were performed using A549 cells.
Transfection of the human airway epithelial cell line A549 with specific siRNA for PPT1 induced more than 95% mRNA down regulation ( Figure 9B ). After the siRNA transfection, cells were exposed to a range of Table 4 : Selected single nucleotide polymorphisms (SNPs) significantly associated with bronchoalveolar lavage (BAL) double-stranded (ds)DNA levels after short-term cigarette smoke (CS) exposure in CS-exposed mice.
Chr. Significant SNPs located within a gene and had less than six mouse strains with missing data. Significance cut-of is set at -log(P)≥6. Number of major and minor alleles indicate the number of mouse strains with the most and least abundant allele for the SNP from the 28 mouse strains used in our analyses. Number of missing alleles indicate the number of mouse strains with missing data for the SNP. Function class is intronic (Int), synonymous-codon (Cs) with the amino acid and location or 3'-untranslated region (UTR). Missing information is noted as unknown (uk). Position is the base pair location of the SNP.
P-value
Figure 5: Haplotype association mapping identifies susceptibility genes for cigarette smoke-independent bronchoalveolar lavage (BAL) double-stranded (ds)DNA levels. The Manhattan plot for the log-transformed BAL dsDNA levels depicts corresponding -log(P) association probabilities for single nucleotide polymorphisms (SNPs) at indicated chromosomal locations. The log-transformed
BAL dsDNA levels of smoke-and air-exposed mice were used as input for the analysis, with air/smoke exposure added to the analysis as covariate. Significance level was set at SNP associations of -log(P) ≤ 5. Blow-ups show genes mapped at the significant SNPs. (see color image on page 214)
Figure 6: Haplotype association mapping identifies susceptibility genes for cigarette smoke-induced bronchoalveolar (BAL) double-stranded (ds)DNA levels. The Manhattan plot for the log-transformed cigarette smoke-induced BAL dsDNA levels depicts corresponding -log(P) association probabilities for single nucleotide polymorphisms (SNPs) at indicated chromosomal locations.
The log-transformed BAL dsDNA levels of only smoke-exposed mice were used as input for the analysis. BALB/cJ and BALB/cByJ mice were excluded from this analysis. Significance level was set at SNP associations of -log(P) ≤ 5. Blow-ups show genes mapped at the significant SNPs. (see color image on page 215) 
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Figure 9: The effect of down regulation of PPT1 on damage associated molecular pattern (DAMP) release and cell death in human alveolar epithelial cells. (A) The human bronchial epithelial cell lines BEAS-2B and 16HBE and the alveolar adenocarcinomic
cell line A549 were exposed to a range of cigarette smoke extract (CSE) for 4 hours (0-100%). The levels of double-stranded (ds)DNA were measured in supernatant after 16 hours of incubation with serum free and CSE-free medium. (B) The level of down-regulation of PPT1 in A549 cells upon treatment with specific small interfering (si)RNA, as analyzed with quantitative RT-PCR, is shown. Data is shown as fold induction of mRNA expression of A549 cells treated with scrambled siRNA assay (2^-dCt ) compared to A549 cells treated with siRNA assay specific for PPT1 (2^-dCt ). The levels of (C) dsDNA and (D) RNA were measured in cell-free supernatant of A549 cells exposed to 0 -100% CSE. Negative control represents untreated cells, scrambled represents cells treated with scrambled siRNA assay and PPT1 siRNA is treated with specific siRNA assays. The levels of (E) viable, (F) apoptotic and (G) necrotic cells were analyzed in A549 cells upon exposure to 0-100% CSE using Annexin-/Propidium Iodide (PI) staining for flow cytometry. All data is shown as mean ± standard error of the mean (SEM). Significance was tested using a Mann-Whitney U test, * = p<0.05, ** = p≤0.01. CSE concentrations (0-100%) for four hours. After 24 hours of incubation with CSE-free medium the amount of necrotic and apoptotic cells and dsDNA release was determined. Upon stimulation with high percentages of CSE (80 -100%), PPT1 down regulation resulted in increased release of dsDNA and RNA and increased levels of both apoptotic and necrotic cell death (Figure 9 ). This indicates that PPT1 down regulation enhances the susceptibility of A549 cells to cell death and DAMP release induced by high CSE concentrations.
Down regulation of ELAC2 using specific siRNA assays induces approximately 80% decrease in mRNA expression ( Figure 10A ). Down regulation of ELAC2 significantly attenuated dsDNA release upon exposure to 60% CSE, apoptotic cell death upon exposure to 0-80% CSE and necrotic cell death upon exposure to 0-40% CSE compared to the scrambled control ( Figure 10 ).
In summary, down regulation of ELAC2 provides protection against CSE-induced cell death and DAMP release upon exposure to low percentages of CSE, while down regulation of PPT1 enhances CSE-induced cell death and DAMP release upon exposure to high percentages of CSE.
Cigarette smoke-induced dysregulation of the expression of candidate genes in epithelium of humans susceptible for the onset of COPD
In order to investigate whether the candidate genes for CS-induced dsDNA release in mice are also regulated by CS exposure in the airway epithelium in human subjects, we analyzed the gene expression of our candidate genes in a microarray gene expression dataset of primary bronchial epithelial cells obtained from bronchial brushings of young healthy individuals. These cells were isolated 24 hours after smoking of three cigarettes within three hour and after two days of smoking cessation, as described previously 54 . Out of the 11 candidate genes, we analyzed expression regulation of 10 candidate genes, since the mouse Aox3l1 gene does not have a human homologue. We found that the gene expression levels of ARHGAP44 and ENOX1 were significantly decreased by exposure to CS ( Table 6 ). None of the eight other candidate genes showed significant changes in gene expression upon CS exposure. The young healthy individuals included in this study were selected to be either susceptible or non-susceptible for the development of COPD based on family history, as described before 24, 54 . In brief, the prevalence of COPD in smoking first-or second-degree relatives older than 40 years was used to classify the young healthy subjects as susceptible (at least 2 out of 3 first-and second-degree 115 | Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice VII smoking relatives developed COPD) or non-susceptible (none of the smoking first-and second-degree relatives developed COPD). When analyzing the interaction between CS exposure and susceptibility for COPD as defined by family history, we observed that the mRNA expression levels of ARHGEF11 and ENOX1 were significantly more decreased by CS in COPD susceptible individuals compared to non-susceptible individuals. Interestingly, in mice the mRNA expression levels of these transcripts were decreased by CS in the non-susceptible strains. In addition, the ELAC2 gene showed a trend (P=0.085) towards a CS-induced decrease between susceptible and non-susceptible individuals. These data show the translation relevance of our findings in mice, indicating that specific identified susceptibility genes for CS-induced dsDNA release in mice are also differently expressed by CS in relation to susceptibility for the development of COPD in humans.
Figure 10: The effect of down regulation of ELAC2 on damage associated molecular pattern (DAMP) release and cell death in human alveolar epithelial cells. (A)
The level of down-regulation of ELAC2 in A549 cells upon treatment with specific small interfering (si)RNA analyzed, as by quantitative RT-PCR, is shown. Data is shown as fold induction of mRNA expression of A549 cells treated with scrambled siRNA assay (2^-dCt ) compared to A549 cells treated with siRNA assay specific for elac2 (2^-dCt ). The levels of (B) double-stranded (ds)DNA and (C) RNA were measured in cell-free supernatant of A549 cells exposed to 0 -100% CSE. Negative control represents untreated cells, scrambled represents cells treated with scrambled siRNA assay and ELAC2 siRNA is treated with specific siRNA assays. The levels of (D) viable, (E) apoptotic and (F) necrotic cells were analyzed in A549 cells upon exposure to 0-100% CSE using Annexin-/Propidium Iodide (PI) staining for flow cytometry. All data is shown as mean ± standard error of the mean (SEM). Significance was tested using a Mann-Whitney U test, * = p<0.05, ** = p≤0.01, *** = p ≤0.001.
DISCUSSION
In the current study we show that CS-induced DAMP release differs between inbred mouse strains, and is genetically regulated by specific genes. We identified 11 candidate genes involved in BAL dsDNA levels in mice, five of which were associated with CS-induced dsDNA release. For two of these candidate genes, Ppt1 and Elac2, we observed that these SNPs act as an eQTL in lung tissue, and display an interaction with susceptibility for CSinduced dsDNA release, indicating that these genes may contribute to the differences in dsDNA release between susceptible and non-susceptible strains. We found that these genes are functionally involved in CS-induced cell death and DAMP release in a human lung epithelial cell line. In addition, we show that two other candidate genes, ARHGEF11 and ENOX1, decreased more in young susceptible individuals compared to non-susceptible individuals. In addition, ELAC2 trended toward a decrease.. Taken together, these data indicate that the severity of CS-induced airway inflammation might be caused by differences in the sensitivity for CS-induced DAMP release.
The role of DAMPs in the pathophysiology of COPD is emerging 47 . DAMPs are released from necrotic or damaged cells and activate the innate immune system by activation of PRRs and by attracting neutrophils 44 .
Previously, we have shown that exposure of human airway epithelial cells to CSE induces DAMP release and subsequent pro-inflammatory responses 23, 50 . Furthermore, we have shown that exposure of mice to CS induces the release of a specific profile of DAMPs in mice susceptible for CS-induced neutrophilic airway inflammation compared to those strains that are not susceptible to this response 48 . In the current study, we employed our existing dataset of 28 different inbred mouse strains exposed to CS for five consecutive days 46 . We found increased levels of all measured DAMPs, i.e. HSP70, HMGB1, mtDNA and dsDNA, in BAL fluid of several but not all mouse strains. The levels of dsDNA showed the highest correlation with CS-induced neutrophil infiltration in BAL fluid, in agreement with our previous study 48 . dsDNA is a widely abundant DAMP that is released by necrotic cells and is not likely to be actively secreted, with the exception of neutrophils undergoing NETosis, making dsDNA a good marker for necrotic cell death 38, 49 . Other DAMPs, including HSP70 and HMGB1 can be both be passively released and actively secreted from several cell-types upon stress 5 . It is likely that the strong correlation between the CS-induced levels of dsDNA in BAL fluid and the number of neutrophils in BAL fluid, can at least in part be explained by neutrophils being the source of the released dsDNA. Nevertheless, the first line of defense against inhaled toxicants is the airway epithelium, providing the first batch of DAMP release, followed by DAMP released from attracted neutrophils 47 . Furthermore, it has been shown that the sputum levels of dsDNA are negatively correlated with FEV1% in patients with cystic fibrosis 39 , indicating that dsDNA release is involved in multiple diseases associated with decreased lung function.
In the current study we identified 11 genes that are significantly associated with dsDNA release in mice.
First we analyzed the genes associated with basal dsDNA release, which identified 9 genes and next we identified 2 more genes which were specifically associated with CS-induced dsDNA release. In the second analysis investigating CS-induced dsDNA release we removed the BALB/cByJ and BALB/cJ strains because the high induction of CS-induced dsDNA release in these strains was masking the identification of susceptibility genes. Nevertheless, this approach may introduce false negative results, as the two most susceptible strains were not included in the analysis. Two of the identified susceptibility genes, Dscaml1 and Enox1, were specifically associated with CS-induced dsDNA release. No direct link in function was observed for these 11 genes using gene ontology annotation. However, five genes have known involvement in cell death pathways, as Cflar, Ppt1, Cap1, Enox1 and Elac2 have shown to be involved in apoptosis and DNA damage responses, indicating that a dysfunctional induction of apoptosis induces increased levels of released dsDNA. Cflar, also called c-Flip, is one of the major components in the apoptotic pathways and it regulates whether a cell goes into apoptosis or necroptosis 53 , making Cflar a relevant candidate gene as apoptotic cells do not release dsDNA, while necroptotic cells do. Moreover, it has been shown that Cflar protects murine fibroblasts against dsRNA-induced apoptosis 21 .
Ppt1 is involved in the regulation of apoptosis, on one hand Ppt1 over-expression induces protection against the induction of apoptosis 9, 13 , and inhibition of Ppt1 induces apoptosis in neuronal cells 10, 11, 20 . While on the 117 | Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice VII other hand PPT1-deficient fibroblasts from mice and humans were protected against TNF-induced apoptosis and restoration of PPT1 increased the susceptibility for apoptosis 55 . This indicates that the effect of Ppt1 on cell death is cell type specific. Cap1 is also involved in apoptosis, as the induction of apoptosis induces the caspaseindependent translocation of Cap1 to the mitochondria which is important for the execution of apoptosis, while the down regulation of Cap1 represses the execution of apoptosis 58 . Furthermore, for Enox1 chemical or genetic inhibition induces apoptosis 19 . Elac2 was shown to be involved in the DNA damage response 52 , which also links it to dsDNA release. For the remaining six genes no connection to cell death or dsDNA release is known to date, however much is unknown about the function of these genes. Of the six genes, for Arhgef11, Dscaml1 and Trip11 as well as for Ppt1 and Elac2 a correlation was shown between the CS-induced gene expression in whole lung tissue of mice and the susceptibility for CS-induced DAMP release. Of note, only for Elac2 and Ppt1 the observed differences in CS-induced gene expression between susceptible and non-susceptible mouse strains was in agreement with the genotype of the SNPs associated with the dsDNA levels in the genetic analysis, underscoring that these SNPs possibly act as an eQTL for these genes. For Ppt1, the gene expression was significantly lower in non-susceptible mouse strains compared to susceptible mouse strains, while exposure to CS decreases the Ppt1 expression in the susceptible mouse strains. For Elac2 the situation was opposite, with increased expression in non-susceptible mouse strains compared to susceptible mouse strains and a down-regulation in gene expression by CS exposure in the non-susceptible strains. The interaction of gene regulation of these two candidate genes with susceptibility for CS-induced dsDNA release strongly argue in favor for a contribution of these genes to the susceptibility for CS-induced dsDNA release.
For the two key candidate genes, Ppt1 and Elac2, we showed that down regulation induces protection The relevance of our candidate genes for COPD patients was further supported by the fact that we identified two genes, ARHGAP44 and ENOX1, of which the expression was decreased in human bronchial epithelial cells 24
hours after smoking three cigarettes in young healthy individuals. Importantly, the gene expression of ARHGEF11
and ENOX1 was significantly more decreased by smoking three cigarettes in young healthy individuals who are susceptible for the development of COPD compared to young healthy individuals who are not. Furthermore, ELAC2 showed a trend towards a stronger CS-induced decrease in susceptible compared to non-susceptible individuals. Although there was a discrepancy between the effect of CS on the expression of ARHGEF11 and ENOX1 in susceptible versus non-susceptible humans and mouse strains, with a stronger decrease by CS exposure in susceptible humans and in non-susceptible mouse strains, our results show that prior to the onset of COPD these genes are already dysregulated, making them likely candidate genes to be causally involved in the disease pathophysiology. Differences in gene expression between our mice and human studies are likely to be caused by differences in the levels of CS exposure, timing and the composition of the investigated cells. Further research is needed to fully elucidate the role of these genes in COPD pathophysiology. Although effectiveness of the classification of susceptible and non-susceptible human individuals in the COPD susceptibility cohort was shown before 16, 24 , the study set-up is prone to induce false positive and negative classifications. First, the (non-) susceptibility traits which are present in smoking first-or second-degree relatives diagnosed with or without COPD are not necessarily inherited by the next generation , potentially leading to false positive or negative classifications. Secondly, genetic recombination and de novo mutations can lead to the presence of susceptibility traits which are not present in non-susceptible relatives, potentially inducing false negative classifications.
Together, the statistical power of the study is limited by the probable number of false positive and negative classifications, nevertheless we were still able to show significant differences between susceptible and non-susceptible individuals.
In summary, with the current study we have identified 11 novel candidate genes for CS-induced dsDNA release in mice. With several validation experiments both in mice and humans we have shown functional or expression-based involvement of eight of the genes in CS-induced cell death and DAMP release. Two key candidate genes were shown to be involved in CSE-induced cell death and DAMP release in the human airway epithelium. These genes are possibly involved in the pathogenesis of diseases where CS exposure induces dsDNA release and subsequent inflammation, e.g. COPD 48, 47 . Further research is needed to elucidate the functional role of the candidate genes in dsDNA release in general and in COPD in specific.
